CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Does peritransplantation use of rituximab reduce the risk of EBV reactivation and PTLPD?
Authors
Wichai Chinratanalab
Brian Engelhardt
+7Â more
Stacey Goodman
John Greer
Madan Jagasia
Adetola Kassim
Paula R Pohlmann
Bipin N Savani
Friedrich Schuening
Publication date
1 January 2009
Publisher
'American Society of Hematology'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Bern Open Repository and Information System (BORIS)
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:boris.unibe.ch:32141
Last time updated on 06/05/2016